CAPSTONE INVESTMENT ADVISORS, LLC - TONIX PHARMACEUTICALS HLDG C ownership

Back to all holdings Add to watchlist

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2021$73,000
-39.2%
57,031
-67.9%
0.00%–
Q4 2020$120,000–177,700–0.00%–
 Download
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q4 2020.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders